Modified thromboelastography evaluation of platelet dysfunction in patients undergoing coronary artery surgery
Author(s) -
Sergey Preisman,
Alexander Kogan,
Kira Itzkovsky,
Gleb Leikin,
Ehud Raanani
Publication year - 2010
Publication title -
european journal of cardio-thoracic surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.303
H-Index - 133
eISSN - 1873-734X
pISSN - 1010-7940
DOI - 10.1016/j.ejcts.2009.12.044
Subject(s) - medicine , clopidogrel , thromboelastography , aspirin , perioperative , platelet , anesthesia , myocardial infarction , discontinuation , thromboelastometry , surgery , cardiac surgery , coronary artery bypass surgery , cardiology , artery
Anti-platelet therapy is associated with increased perioperative bleeding. Although current guidelines call for its caessation 5-10 days prior to cardiac surgery, this could constitute an increased risk of preoperative myocardial infarction. The optimal safe period from discontinuation of anti-platelet therapy to surgery is as yet unknown for the individual patient. We investigated whether preoperative thromboelastography (TEG) with platelet mapping could predict bleeding tendency in patients (on recent anti-platelet therapy) undergoing coronary artery bypass grafting (CABG).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom